Ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence StudyInterventional

A bioequivalence vasoconstriction study comparing two clobetasol propionate 0.5 mg/g ointments after skin application in healthy adult human subjects

At a glance

Status

Ongoing, recruiting

Phase

Human Pharmacology (Phase I)- Bioequivalence Study

Sponsor

BELUPO lijekovi i kozmetika d.d.

Enrolment target

100

Start

11 Sep 2023

Localized therapy-resistant inflammatory skin diseases for which the use of topical corticosteroids with very high potency is indicated.

Who may be eligible?

Age 18 Years to any · Sex: All

Locations (1)

—
Poland

How to find out more

Official trial record

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.